Crestchem Limited (BOM:526269)
93.86
+3.86 (4.29%)
At close: Feb 12, 2026
Crestchem Revenue
Crestchem had revenue of 71.93M INR in the quarter ending September 30, 2025, a decrease of -7.82%. This brings the company's revenue in the last twelve months to 242.52M, down -6.86% year-over-year. In the fiscal year ending March 31, 2025, Crestchem had annual revenue of 250.77M with 17.98% growth.
Revenue (ttm)
242.52M
Revenue Growth
-6.86%
P/S Ratio
1.16
Revenue / Employee
60.63M
Employees
4
Market Cap
281.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 250.77M | 38.21M | 17.98% |
| Mar 31, 2024 | 212.56M | 45.28M | 27.07% |
| Mar 31, 2023 | 167.28M | 87.81M | 110.49% |
| Mar 31, 2022 | 79.47M | 3.06M | 4.00% |
| Mar 31, 2021 | 76.42M | 14.37M | 23.16% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Resonance Specialties | 899.72M |
| Tyche Industries | 570.25M |
| Vasundhara Rasayans | 315.86M |
| Link Pharma Chem | 258.97M |
| Krebs Biochemicals & Industries | 230.23M |
| Ishita Drugs and Industries | 161.68M |
| Accretion Nutraveda | 160.49M |